Tennessee Court Rules Generic Lovenox Class-Action Suit Can Continue

A Tennessee federal court granted class action status for a lawsuit by buyers against Sandoz and Momenta over price-fixing allegations.

The two drugmakers were sued by Nashville General Hospital and the American Federation of State, County, and Municipal Employees District Council 37 Health and Securities Plan in 2015 for an alleged conspiracy to monopolize the production and distribution of generic enoxaparin, commonly used to treat blood clots. Sanofi-Aventis, which is not named in the suit, is the name-brand manufacturer of enoxaparin, which is sold as Lovenox.

The complaint in the U.S. District Court for Middle Tennessee alleges that Momenta and Sandoz entered into a collaboration agreement in 2005, under which the companies agreed to share the profits of Sandoz’s generic enoxaparin so long as they remained the sole source of the generic drug in the U.S.